Corvel Return on Equity

Corvel (CRVL) currently reports a ROE of 21.65%. That is below the Healthcare sector average of 22.76%. Use the charts on this page to explore Corvel's ROE history and peer comparisons.

Corvel's ROE of 21.65% is lower than the Healthcare sector average of 22.76%. That is roughly 4.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Corvel's current 21.65% should be judged against Healthcare norms (sector average: 22.76%) and against CRVL's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 21.65%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 22.76%. From there, open related valuation or income-statement pages for Corvel, and consider following CRVL for alerts when major investors trade the stock.

Corvel is classified in the Healthcare sector. On ROE, it currently shows 21.65% versus a sector average near 22.76%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CRVL with unrelated industries.